Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
US11077053B2 · kind B2 · utility
1Cited by
12References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2020 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Nov 17, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0051
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using the alpha-2-adrenergic receptor agonist of Formula I:for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.